BIOGEN IDEC INC. - US09062X1037 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
104,25 EUR
|
0,00% |
16.04.2025 09:17
|
51,00 |
102,95 |
104,75 |
126,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
31
1
32
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
41
0
41
Balance ratios |
2024 |
2023 |
Total assets |
28.049.300 USD |
26.844.800 USD |
Employees |
7.605 |
7.570 |
Cash and cash equivalents |
2.375.000 USD |
1.049.900 USD |
Intangible / inalienable assets |
16.170.100 USD |
14.582.200 USD |
Economic shareholder's equity |
16.716.000 USD |
14.799.400 USD |
Subscribed Capital |
100 USD |
100 USD |
Liabilities |
11.333.300 USD |
12.045.400 USD |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2024 |
2023 |
Sales |
9.266.600 USD |
9.417.000 USD |
Profit after tax |
1.632.200 USD |
1.161.500 USD |
Deprecation (??) |
673.200 USD |
494.800 USD |
Dividend ordinary shares |
- |
- |
Net investment income |
- |
- |
Dividend preferred shares |
- |
- |
Net interests income |
-185.900 USD |
7.900 USD |
Earnings from ordinary operating activities |
1.906.000 USD |
1.296.800 USD |
Net income (after minority interests) |
1.632.200 USD |
1.161.100 USD |
Net earnings per share |
11.18 USD |
7.97 USD |
Total payout |
0 USD |
0 USD |
Administrative expenses |
- |
- |